Nplate administration kit development for the treatment of approved indications, including acute radiation syndrome (ARS)
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50123C00040
- Awardee
-
Amgen Inc. UEI D92HARF1LKA9
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $7,290,924
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 100% obligated
- $7,290,923.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost Sharing
- Place of performance
- Thousand Oaks, CA 91320, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to Amgen Inc., a for-profit manufacturer, to develop an NPLATE administration kit for the treatment of approved indications, including Acute Radiation Syndrome (ARS). The contract is a definitive, cost-sharing contract with a potential value of $7,290,923.50 and a completion date of August 27, 2026. The contract award is not associated with a set-aside designation. The original solicitation was a Broad Agency Announcement (BAA) from BARDA, which sought proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats, including vaccines, therapeutics, diagnostics, and other relevant technologies.
Quick answers
Who was awarded contract 75A50123C00040?
75A50123C00040 was awarded to Amgen Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 28, 2023.
How much is contract 75A50123C00040 worth?
The government has obligated $7,290,924 on 75A50123C00040.
Was contract 75A50123C00040 competed?
The extent of competition for 75A50123C00040 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award